Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. (SHE:301584)
22.45
+0.66 (3.03%)
Jun 24, 2026, 4:00 PM EDT
SHE:301584 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,856 | 1,788 | 1,487 | 1,051 | 577.97 |
Trading Asset Securities | 70.81 | - | - | - | - |
Cash & Short-Term Investments | 1,927 | 1,788 | 1,487 | 1,051 | 577.97 |
Cash Growth | 7.75% | 20.24% | 41.54% | 81.80% | -15.22% |
Accounts Receivable | 8,006 | 6,593 | 6,152 | 5,392 | 5,141 |
Other Receivables | 182.33 | 142.83 | 145.81 | 75.3 | 1.48 |
Receivables | 8,188 | 6,736 | 6,298 | 5,468 | 5,142 |
Inventory | 3,447 | 3,479 | 2,513 | 1,841 | 1,229 |
Other Current Assets | 657.69 | 593.16 | 448.18 | 419 | 430.07 |
Total Current Assets | 14,220 | 12,596 | 10,746 | 8,778 | 7,379 |
Property, Plant & Equipment | 270.14 | 289.54 | 236.6 | 135.71 | 104.07 |
Goodwill | 37.31 | 40.2 | 40.2 | 37.31 | 37.31 |
Other Intangible Assets | 7.13 | 5.73 | 7.33 | 7.37 | 7.92 |
Long-Term Accounts Receivable | - | 22.22 | 14.25 | 4.14 | 23.44 |
Long-Term Deferred Tax Assets | 101.9 | 80.05 | 72.01 | 69.62 | 48.46 |
Long-Term Deferred Charges | 80.73 | 68.19 | 46.81 | 19.96 | 4.47 |
Other Long-Term Assets | 35.43 | 10.54 | 8.26 | 4.5 | - |
Total Assets | 14,752 | 13,112 | 11,171 | 9,057 | 7,605 |
Accounts Payable | 7,820 | 6,317 | 5,230 | 4,562 | 4,829 |
Accrued Expenses | 212.09 | 217.45 | 209.15 | 177.39 | 150.72 |
Short-Term Debt | 3,459 | 3,854 | 3,528 | 2,388 | 1,027 |
Current Portion of Long-Term Debt | - | - | - | - | 154.06 |
Current Portion of Leases | - | - | - | - | 24.51 |
Current Income Taxes Payable | - | 34.46 | 32.02 | 28.83 | 26.47 |
Current Unearned Revenue | 418.65 | 558.46 | 405.48 | 414.89 | 182.06 |
Other Current Liabilities | 317.9 | 261.81 | 201.25 | 177.45 | 86.37 |
Total Current Liabilities | 12,228 | 11,243 | 9,606 | 7,749 | 6,481 |
Long-Term Debt | - | 23.18 | 69.53 | 115.88 | 89.22 |
Long-Term Leases | 60.79 | 68.68 | 63.12 | 48.16 | 27.94 |
Long-Term Unearned Revenue | - | 0.01 | 0.05 | - | - |
Long-Term Deferred Tax Liabilities | 0.27 | 0.63 | 1.28 | 0.02 | 0.47 |
Other Long-Term Liabilities | - | - | - | 1.21 | 13.97 |
Total Liabilities | 12,289 | 11,335 | 9,740 | 7,914 | 6,612 |
Common Stock | 421.29 | 358.1 | 358.1 | 358.1 | 358.1 |
Additional Paid-In Capital | 345.2 | 38.23 | 36.71 | 31.36 | 26.28 |
Retained Earnings | 1,355 | 1,085 | 856.59 | 660.29 | 557.63 |
Total Common Equity | 2,121 | 1,481 | 1,251 | 1,050 | 942.01 |
Minority Interest | 342.16 | 295.37 | 179.95 | 92.73 | 50.94 |
Shareholders' Equity | 2,463 | 1,777 | 1,431 | 1,142 | 992.95 |
Total Liabilities & Equity | 14,752 | 13,112 | 11,171 | 9,057 | 7,605 |
Total Debt | 3,520 | 3,946 | 3,661 | 2,552 | 1,323 |
Net Cash (Debt) | -1,593 | -2,157 | -2,174 | -1,501 | -744.9 |
Net Cash Per Share | -4.20 | -6.05 | -6.09 | -4.22 | -2.10 |
Filing Date Shares Outstanding | 420.61 | 358.1 | 356.92 | 355.67 | 358.1 |
Total Common Shares Outstanding | 420.61 | 358.1 | 356.92 | 355.67 | 358.1 |
Working Capital | 1,992 | 1,353 | 1,140 | 1,029 | 898.88 |
Book Value Per Share | 5.04 | 4.14 | 3.51 | 2.95 | 2.63 |
Tangible Book Value | 2,077 | 1,435 | 1,204 | 1,005 | 896.78 |
Tangible Book Value Per Share | 4.94 | 4.01 | 3.37 | 2.83 | 2.50 |
Buildings | - | 45.33 | 45.33 | 45.33 | 45.33 |
Machinery | - | 192.42 | 116.86 | 35.6 | 14.13 |
Construction In Progress | - | 1.41 | 1.13 | - | 1.54 |